BioSpace News Archive

According to new data from the EAST-AFNET 4 trial that was released on Aug. 29, patients with atrial fibrillation appear to benefit from early rhythm control therapy.

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 2, 2020.

The rolling NDA was somewhat expected after an end-of-phase meeting with the FDA earlier this year turned into a pre-NDA meeting with the regulatory agency.

NeuPath Health Inc. (TSXV:NPTH) (“NeuPath” or the “Company”), Canada’s largest provider of chronic pain management services, announced today a grant of 461,080 stock options (“Options”) to directors, officers and certain employees of the Corporation at an exercise price of $0.87 per share, with an expiry date of September 1, 2027.

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that management, will present at the LD Micro’s “LD 500" Virtual Investor Conference, on Wednesday, September 02, 2020 3:40 PM Eastern Time.

iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today reported financial results for the second quarter ended June 30, 2020 and recent business highlights.

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)(NASDAQ:ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it will be presenting at the LD Micro 500 Virtual Investor conference being held virtually on September 1-4, 2020.

PicnicHealth, the venture-backed startup that gives patients unprecedented access to their medical records and the ability to contribute to scientific research, today announced $35 million in equity financing, including a new $25 million Series B led by Felicis Ventures, and a previously-unannounced $10 million Series A led by Amplify Partners in 2018.

Noted Diagnostic Industry Veteran David B. Perez Joins as an Independent Director Chris Smith Appointed Chairman of the Board, in addition to current CEO role

Catalyst @ Health 2.0, the industry leader in digital health strategic partnering, announced today the launch of The COVID-19 Symptom Data Challenge.